- Discovery proteomics service for biofluids delivering deep, unbiased protein profiling across plasma, serum, CSF, urine, and other complex biological matrices.
- High-resolution LC-MS–based proteomics providing exceptional protein coverage and reproducibility for large-scale, discovery-driven studies.
- Biofluid proteomics platform supporting biomarker discovery, drug response analysis, disease mechanism research, and translational and clinical applications.
Pioneering Breakthroughs with Discovery
Panome Bio’s discovery proteomics for biofluids approach utilizes a nanoparticle-based proteomic analysis technology to take a deeper look at the proteome.
The technology allows detection across a broader range of proteins, including low-abundant proteins missed by other approaches, enabling more impactful biomarker discovery. Panome Bio pairs the Seer Proteograph with the Thermo Fisher Orbitrap Astral mass spectrometer to achieve the broadest coverage possible with a high-throughput workflow.
Advantages of our Discovery Proteomics Platform:
- Detects protein variants and post-translational modifications
- Allows for broader coverage by capturing more low-abundance proteins that with traditional methods
- Optimized for biofluids such as plasma, serum, urine, cerebrospinal fluid (CSF), or conditioned culture media of multiple species
- Enables comprehensive and in-depth proteomic profiling
Global Proteomics Analysis of Serum from Health and Colon Cancer Patients
See how untargeted proteomics is applied to Colorectal Cancer
Let’s get started!
Discover the unparalleled advantages of Panome Bio’s advanced proteomics technology. With a comprehensive view of the proteome, the experts at Panome Bio can perform robust proteomics analyses, profile unknown peptide variants, and achieve insights that were previously not possible.
Ready to elevate your research? Connect with us today and transform your proteomics outcomes.